Total Payments
$5,481
2022 Payments
$14.47
Companies
30
Transactions
364
Medicare Patients
3,438
Medicare Billing
$176,367
Payment Breakdown by Category
Food & Beverage$5,464 (99.7%)
Education$17.22 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,464 | 361 | 99.7% |
| Education | $17.22 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,092 | 51 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $929.43 | 62 | $0 (2021) |
| PFIZER INC. | $609.32 | 62 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $550.62 | 41 | $0 (2021) |
| Mylan Specialty L.P. | $379.44 | 30 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $328.28 | 15 | $0 (2021) |
| GlaxoSmithKline, LLC. | $273.33 | 22 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $267.88 | 19 | $0 (2018) |
| Amgen Inc. | $248.36 | 10 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $131.16 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.47 | 1 | GlaxoSmithKline, LLC. ($14.47) |
| 2021 | $355.81 | 23 | Lilly USA, LLC ($59.87) |
| 2020 | $246.79 | 10 | Novo Nordisk Inc ($160.88) |
| 2019 | $1,379 | 78 | Novo Nordisk Inc ($399.37) |
| 2018 | $1,743 | 121 | Novo Nordisk Inc ($317.75) |
| 2017 | $1,742 | 131 | SANOFI-AVENTIS U.S. LLC ($278.46) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/10/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/13/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Obesity | ||||||
| 06/30/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Obesity | ||||||
| 06/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiovascular | ||||||
| 06/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: DIABETES | ||||||
| 05/19/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 05/04/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Obesity | ||||||
| 05/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/21/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, TRIJARDY XR | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 04/12/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 04/06/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/29/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: PRIMARY CARE | ||||||
| 03/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiovascular | ||||||
| 03/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Cardiovascular | ||||||
| 03/10/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 03/08/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Obesity | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 23 | 1,123 | 1,638 | $171,838 | $51,330 |
| 2020 | 36 | 2,315 | 3,833 | $400,371 | $125,037 |
Total Patients
3,438
Total Services
5,471
Medicare Billing
$176,367
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 218 | 466 | $104,682 | $29,267 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 96 | $14,784 | $3,995 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 27 | 27 | $6,607 | $3,330 | 50.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 31 | 31 | $5,454 | $2,273 | 41.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 126 | 126 | $5,040 | $1,665 | 33.0% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 49 | 49 | $3,871 | $1,598 | 41.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 124 | 126 | $4,410 | $1,313 | 29.8% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2021 | 67 | 91 | $2,149 | $1,231 | 57.3% |
| 82306 | Vitamin d-3 level | Office | 2021 | 36 | 37 | $2,035 | $1,095 | 53.8% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 49 | 49 | $3,871 | $1,037 | 26.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 71 | 88 | $2,640 | $838.33 | 31.8% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2021 | 13 | 15 | $1,425 | $588.90 | 41.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 54 | 67 | $1,675 | $512.82 | 30.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 26 | 27 | $1,524 | $453.60 | 29.8% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 23 | 23 | $1,708 | $409.87 | 24.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 12 | 12 | $1,704 | $406.56 | 23.9% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 14 | 14 | $1,610 | $369.80 | 23.0% |
| 85610 | Blood test, clotting time | Office | 2021 | 18 | 71 | $1,065 | $304.59 | 28.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 17 | 17 | $935.00 | $281.26 | 30.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 26 | 36 | $1,979 | $250.08 | 12.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $468.24 | $90.21 | 19.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 20 | 124 | $1,488 | $11.47 | 0.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 14 | 34 | $714.00 | $7.90 | 1.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 262 | 884 | $198,582 | $55,480 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 118 | 118 | $28,875 | $12,786 | 44.3% |
About Dr. Paul Warrington, MD
Dr. Paul Warrington, MD is a Family Medicine healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831168350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Warrington, MD has received a total of $5,481 in payments from pharmaceutical and medical device companies, with $14.47 received in 2022. These payments were reported across 364 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,464).
As a Medicare-enrolled provider, Warrington has provided services to 3,438 Medicare beneficiaries, totaling 5,471 services with total Medicare billing of $176,367. Data is available for 2 years (2020–2021), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cleveland, MS
- Active Since 03/16/2006
- Last Updated 11/08/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831168350
Products in Payments
- FARXIGA (Drug) $409.41
- Ozempic (Drug) $336.69
- Victoza (Drug) $293.97
- SOLIQUA (Drug) $286.34
- ENTRESTO (Drug) $253.46
- Tresiba (Drug) $239.72
- BYDUREON (Drug) $186.71
- BEVESPI AEROSPHERE (Drug) $186.57
- JARDIANCE (Drug) $183.00
- Yupelri (Drug) $167.18
- TOVIAZ (Drug) $160.07
- VIAGRA (Drug) $158.97
- TOUJEO (Drug) $158.45
- CHANTIX (Drug) $156.90
- Repatha (Biological) $151.68
- Dymista (Drug) $126.80
- PRADAXA (Drug) $124.67
- ANORO (Drug) $117.43
- Xultophy 100/3.6 (Drug) $114.32
- LONHALA MAGNAIR (Drug) $101.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Family Medicine $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Family Medicine $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
Family Medicine $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Family Medicine $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Family Medicine $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499
Family Medicine $9,499